Sodium-Glucose Transporter 2 Inhibitors
7 clinical trials · Condition
◉ Watch Sodium-Glucose Transporter 2 Inhibitors
| Record | Firm | Date |
|---|---|---|
| Empagliflozin in Diuretic Refractory Ascites (NCT05013502) | Stanford University | 2021-11-15 |
| Effect of Dapagliflozin on Body Weight in Overweight Women Consuming Different Proportions of Carbohydrate Diet. (NCT06383832) | Sun Jia | 2021-10-28 |
| Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production (NCT03852901) | National Institute on Aging (NIA) | 2019-03-28 |
Track Sodium-Glucose Transporter 2 Inhibitors automatically
Every clearance here is in the API, with alerts when new ones post.